Regeneron Pharmaceuticals (REGN)
EBITDA Margin
37.01%
TTM · Period ending:
REGN EBITDA Margin
Latest reported37.01%period ending
Latest reported37.01%period ending
REGN EBITDA Margin (-60.00% → 37.01%)
Annual ebitda margin
High-resolution chart · PNG
REGN ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 40.565% | |
| 37.4454% | |
| 35.7797% | |
| 43.2075% | |
| 60.1635% | |
| 48.2894% | |
| 40.71% | |
| 40.6792% | |
| 38.3006% | |
| 29.6631% | |
| 32.0257% | |
| 30.7071% | |
| 38.0569% | |
| 36.03% | |
| -38.2501% | |
| -16.4817% | |
| -14.5986% | |
| -25.7153% | |
| -65.6434% | |
| -120.5967% | |
| -102.5728% | |
| 39.7869% | |
| -159.1613% | |
| -516.1861% | |
| -362.2901% | |
| -35.1829% | |
| -59.1304% | |
| -24.8691% | |
| -28.0967% | |
| -46.473% | |
| -6.2044% | |
| -107.7586% | |
| -336.7925% | |
| -141.7391% | |
| -120.5479% | |
| -60% |